FDA’s Sentinel Framework Should Preclude “Unbridled” Data Mining – Platt
Executive Summary
FDA's nascent electronic post-market drug safety monitoring project - Sentinel - should be designed to investigate only known problems or specific issues raised by spontaneous reports or studies, Harvard University's Richard Platt recommends
You may also be interested in...
Aetna Plans “Clinical Alert” On Plavix Use With PPIs Based On Claims Review
Aetna is developing a clinical alert for physicians and pharmacists to warn about potentially reduced effectiveness for Plavix (clopidogrel) when the antiplatelet drug is used concurrently with a proton pump inhibitor, such as Prilosec (omeprazole) or Nexium (esomeprazole)
Aetna Plans “Clinical Alert” On Plavix Use With PPIs Based On Claims Review
Aetna is developing a clinical alert for physicians and pharmacists to warn about potentially reduced effectiveness for Plavix (clopidogrel) when the antiplatelet drug is used concurrently with a proton pump inhibitor, such as Prilosec (omeprazole) or Nexium (esomeprazole)
E-Prescribing Incentives Offer Model For Electronic Records – CBO’s Orszag
Proponents of the universal adoption of electronic health records might look to follow the "carrot and stick" incentives for electronic prescribing created by the new Medicare Improvements Act, Congressional Budget Office Director Peter Orszag suggests